Introduction
Post-myocardial infarction (MI) depression is a highly prevalent disorder, affecting nearly 18% of all MI patients [1, 2] , and it is a major predictor of disability in the year post-MI. Moreover, the question arises whether depression following MI is a risk factor for cardiovascular morbidity and mortality. Although the number of positive studies in this field has been growing steadily, the discrepancies have continued since the publication of a few negative results [3] [4] [5] [6] [7] [8] [9] . Scant studies have Seyed Hamzeh Hosseini et al., Anxiety and depression as predictors of MI mortality reported longer-term mortality data in MI patients; whereas one has found an association between an in-hospital depression and mortality 5 years later [10] , the other has observed no association at 3-year follow-up [11] . Although symptoms of depression and anxiety overlap, little is known about how anxiety affects mortality, with reports of both positive and negative effects [12] [13] [14] [15] .
These apparently conflicting results prompted us to find an answer to the following question: "Is there any association between depression and the cardiovascular mortality following MI"? We had previously found that depression or anxiety would not predict a subsequent increase in mortality during a 24-month follow-up period after MI [8] . We sought to expand this analysis by: comparing case-level anxiety, depression, and comorbid anxiety and depression as predictors of long term mortality during a 5-year follow-up period after MI; and investigating the role of potential modifying and confounding factors.
Methods
Between 2005 and 2010 all consecutive patients admitted to the coronary care units at Razi Hospital (Mazandaran University of Medical, Ghaemshahr, Iran) and Fatemeh Zahra Hospital (Mazandaran University of Medical, Sari, Iran) who met established criteria for MI were eligible for inclusion in the study. Patients were included if they met World Health Organization criteria for MI during their hospital admission [16] . Patients were excluded from the study if MI was the result of coronary artery bypass graft surgery or angiography, if they had another medical condition likely to lead to death within the next 5 years and if they were unstable medically to complete the assessment even with assistance from the researcher. There were no age or gender restrictions. The study was approved by the ethics committees of the hospitals and was conducted in accordance with Helsinki Declaration.
Patients meeting the inclusion criteria were asked to participate as soon as they were medically stable and had been informed of their diagnosis, on average 6 days after their MI (range 2-15 days). After explaining the study and obtaining written informed consent, a research psychologist (investigator) conducted all baseline interviews which gathered routine demographic data, including age, gender, education, current partner status, history of smoking and alcohol use, history of thrombolytic therapy and any past medical history, including history of cardiovascular disease, diabetes mellitus, hypertension and past psychiatric history. Patients also completed a series of questionnaires. The 21--item self-report Beck Depression Inventory (BDI) whose validity and reliability has been previously approved in Iran [17, 18] was used to assess the then current depressive symptoms. Scores of 10 or higher were considered to indicate the presence of mild to severe symptoms of depression [19] . Anxiety was assessed with the Persian version of the Spielberger's State-Trait Anxiety Inventory (STAI). The Persian version of STAI had been used in previous studies and its validity and reliability had been approved [20, 21] . The STAI, which comprises two self-report scales, was used to assess state anxiety. Scores of 40 or higher indicated the presence of anxiety symptoms [22] .
The main outcome of this study was a 5-year cardiac mortality. We tested the BDI × STAI interaction effect in addition to the BDI and STAI main effects. Employing these cut-offs, four groups were identified for the analysis: case-level anxiety only, case-level depression only, case-level comorbid anxiety and depression, and a reference group scoring below case-level on both scales.
Statistical analysis
Data were analyzed using SPSS for Windows, version 20. All statistical tests were 2-tailed; p values < 0.05 were considered statistically significant. Categorical variables were compared using the c 2 statistic or Fisher's exact test, if necessary. Continuous variables were compared using independent sample t-tests. The key outcome was cardiac mortality after MI. Cox regression models were used to quantify associations between anxiety, depression and mortality, for investigation of confounding/mediating factors all demographic, clinical, and psychological variables that differentiated patients who died from those who survived were entered into a regression model. The same analyses were constructed for the dichotomized BDI (BDI score < 10 or ≥ 10, respectively) and state anxiety scores (dichotomized as < 40 and ≥ 40).
Results are presented as hazard ratios (HR) with 95% confidence interval (CI). Individuals still alive at the end of the follow-up comprised a common reference category.
Results

Participant characteristics
The mean age of participants was 59.1 ± 12.03 years (range 24-85 years) and 197 (69.1%) were male; 105 (36.8%) participants were hypertensive, 61 (21.4%) were diabetics, and 77 (27.0%) were current cigarette smokers; 39 (13.7%) participants had suffered a previous MI and 105 (36.8%) received thrombolytic therapy. Tables 1 and 2 show the baseline demographic, clinical and psychological information for participants with relatively high scores of depression and anxiety compared to those with relatively low scores during their hospital admission after acute MI. At entry, BDI score of 192 (67.4%) patients was ≥ 10 and 145 (50.9%) cases had STAI score ≥ 40, respectively.
Baseline characteristics as a function of BDI or STAI status
There were several differences between the groups: those with high BDI scores were more likely to be female, to have hypertension, diabetes or history of a previous MI, less to be current smokers, and to have lower educational level. Anxiety was significantly associated with hypertension and lower educational level. Aside from a substantial association with state anxiety, BDI status was linked only to sex and diabetes in univariate analysis; women and patients with diabetes were more likely to register BDI scores ≥ 10.
Mortality and depression and anxiety disorders
Of the 285 completed baseline assessments, 274 were traced on 5 years of follow-up. Of the 274 patients whose survival data were available, 91 (33.2%) died. Non-participants (patients who did not participate in the follow-up) were heterogeneous but did, on average, have poorer health than the participants. Comparison of the 91 dead subjects with the 183 living cases at the time of final assessment has been summarized in Table 3 . Females were more likely to die, and the patients who died during the 5-year follow-up period were significantly older than those who survived, had more history of previous MI, received more thrombolytic therapy in the Index MI and had significantly higher BDI scores.
The data in Table 3 indicate that those who had died had higher BDI scores (depression score) at entry, but STAI score (anxiety score) was not After adjustment for age and gender, the associations among BDI score and mortality weakened but remained significant (unadjusted HR 1.032, 95% CI 1.008-1.057, p = 0.010; adjusted HR 1.027, 95% CI 1.0-1.054). When the relative contribution of all the above mentioned variables singly related to outcome was analyzed by cox regression analysis, older age (HR 1.096, 95% CI 1.062-1.132, p < 0.0001), and history of diabetes (HR 2.675, 95% CI 1.191-6.008, p = 0.017) or previous MI (HR 3.181, 95% CI 1.329-7.615, p = 0.009) remained significantly and independently associated with mortality; the associations among BDI score and mortality attenuated to a non-significant trend (HR 1.017, 95% CI 0.987-1.047, p = 0.269).
Analysis of comorbidity
The diagnoses of depression and anxiety were significantly correlated (r = 0.269, p < 0.0001).
There were 74 (27.0%) cases with only depression and 26 (9.5%) with only anxiety; 110 (40.1%) participants had a diagnosis of both depression and anxiety. Percentages of patients who died with both comorbidities, depression only, anxiety only or neither are shown in Figure 1 . There was no significant difference between the four study groups in the mortality rate. Simple effect analyses indicated that neither the value of depression for predicting cardiac mortality varied by the severity of comorbid anxiety, nor the value of anxiety for predicting cardiac mortality varied by the severity of comorbid depression. When comorbid with case--level depression, case-level anxiety was associated with a non-significant reduction in mortality (data not shown). 
Discussion
In the present analysis, anxiety was not associated with mortality, whereas depression significantly predicted death, but this association was abolished with full adjustment. Our finding of stronger mortality association in female participants between depression and mortality contrasts with the previously reported stronger effect in men than in women [23, 24] .
A number of previous studies have evaluated both anxiety and depression disorders and mortality in MI patients. High depression and anxiety values have both been shown to predict subsequent mortality [3, 7] . However, in some cases, symptoms of depression but not anxiety in multivariate models predicted mortality [5, 6] , and in some, neither depression nor anxiety symptoms were found to predict mortality in MI patients [9] . Because the studies have varied in location, patient population, sample size, and the means of measuring depression, some variation in results is hardly surprising. In a previous analysis, we found that depression was not a stronger risk factor for post-MI mortality than for other causes combined during a 24-month follow-up [8] . A meta-analysis in 2004 [2] reported that post-MI depression is associated with a 2-to 2.5-fold increased risk of impaired cardiovascular outcome, and a recent meta-analysis in 2013 indicated that, although the association between depression following MI and prognosis is attenuated after adjustment for cardiac disease severity, depression remains independently associated with prognosis with a 22% increased risk of all-cause mortality and a 13% increased risk of cardiovascular events per standard deviation in depression z-score [25] . The relation of depression with cardiac mortality or all-cause mortality was more significant in the older studies (OR 3.22 before 1992) than in the more recent studies (OR 2.01 after 1992). This is despite the fact that in the recent large-scale intervention trial in MI patients with major or minor depression, the successful treatment of depression was successful in reducing symptoms, however it did not reduce mortality or the recurrence of MI over the average follow-up period of 41 months [26] .
It seems more likely that controversies in results of depression and mortality in MI patients hinge on the issue of the relation between depression and disease severity. Depression and anxiety were associated with disease severity in some previous studies showing a relationship between these conditions and post-MI mortality and that disease severity is the underlying cause of death. It is worth noting that in a number of studies in which symptoms of depression were related to both short-term mortality following MI and disease severity, statistical control for disease severity attenuated the significant association between depression and mortality [27] [28] [29] [30] . In some previous studies, depression was associated with the severity of cardiac disease. Therefore, the possibility of confounding factors that reduce the strength of the association between post-MI depression and cardiovascular prognosis cannot be fully ruled out. That is why depression and disease severity might be correlated in some studies but not in others; Carroll and Lane [31] have argued that it depends on the accuracy of patients' perceptions of just how serious the event was and the likely prognosis.
The failure of some previous studies with negative results regarding the relationship between depression or anxiety with post-MI mortality, is attributed to the prevalence of mild symptoms among their patients [4, 32] . However, 67.4% of our patients scored ≥ 10 on the BDI and 50.9% scored ≥ 40 on the STAI, indicating mild to severe symptoms of depression and anxiety, respectively.
Depression and anxiety are highly comorbid psychiatric conditions [33] . In the present study, 40.3% of total participants had a diagnosis of both depression and anxiety. More strikingly, 59.9% of those with a diagnosis of depression also had anxiety. The literature on anxiety and mortality is relatively sparse compared to that on depression. Previous studies have reported conflicting findings concerning the association between anxiety levels and mortality, which was reported as positive [12] , absent [13, 14] , and negative [15] . Furthermore, we found lower mortality in participants with comorbid anxiety and depression compared to those with depression alone. The latter finding is contrary to what seems intuitive, since comorbid anxiety and depression are associated with both poorer physical health [34] and more disability [35] than depression alone. We guess that low anxiety may result in reduced asking for help and reduced adherence to medications when somatic illness occurs [36] , and may promote earlier identification and treatment of potentially life threatening disease and/or decrease risk behavior associated with non-disease mortality [15] . In other words, there may be an evolutionary benefit of moderate levels of anxiety, a hypothesis that needs further demonstration. These findings of differences between anxiety and depression might be an argument for maintaining the separation of the two disorders. Confounding is also unlikely since there was no apparent alteration following adjustment for the large number of covariates available for this analysis.
Limitations of the study
It should be conceded that there are a number of limitations to this analysis and its interpretation. First, our patients were hospitalized only for a few days and we did not regard the fluctuating distress reported by patients immediately after an MI as true depressive disorder. Furthermore, patients who were depressed at baseline were less likely to accept follow-up interviews than other patients. However, depression and anxiety at baseline were not related to lack of follow-up, so it is unlikely that the lack of interview data biased the results. To establish a causal relationship, we need longitudinal research combining repeated measurement of depression and its presumed pathophysiological mechanisms, followed by adequately powered, randomized trials targeting the implicated mechanisms.
Conclusions
In conclusion, the present analysis showed that anxiety symptoms were not associated with mortality, whereas depressive symptoms significantly predicted death, but this association was attenuated to no significance with full adjustment. In spite of non-significant results, with regard to the impact of depression and anxiety on cardiac outcome, it should be stressed that this does not mean that physicians and cardiologists can ignore depression.
